KRIBIOLISA™ Anti-Natalizumab (TYSABRI) ELISA
Enzyme Immunoassay for the quantitative determination of Anti-Natalizumab antibodies in serum and plasma.
Receive your quote directly from the manufacturer.
Intended Use:
The KRIBIOLISA™ Anti-Natalizumab ELISA is used as an analytical tool for quantitative determination of Anti-Natalizumab in serum, plasma and cell culture supernatant.
Principle:
The method employs the quantitative sandwich enzyme immunoassay technique. Natalizumab is pre-coated onto microwells. Samples and standards are pipetted into microwells and antibodies to Natalizumab present in the sample are bound by the capture antibody. Then, a HRP (horseradish peroxidase) conjugated Natalizumab is pipetted and incubated. After washing microwells in order to remove any non-specific binding, the ready to use substrate solution (TMB) is added to microwells and color develops proportionally to the amount of Anti-Natalizumab in the sample. Color development is then stopped by addition of stop solution. Absorbance is measured at 450 nm.
- Calibrator Range: 0 ng/ml - 640 ng/ml
- Sensitivity: 10 ng/ml
- Sample Type: serum, plasma and cell culture supernatant
- Shipping Condition: 2 - 8 Deg C
- Detection Method: Colorimetric
- Usage: For In-Vitro Diagnostic Use Only
- Research Area: Therapeutic Drug Monitoring
Krishgen kits have over 1000 citations, with our ELISA kits being used for publications in 15+ countries.
